A MULTICENTER, 3-ARM, OPEN-LABEL, PHASE IIA CLINICAL TRIAL TO EVALUATE SAFETY AND EFFICACY OF TANIBIRUMAB (VEGFR2 MAB), IN PATIENTS WITH RECURRENT GBM ASSESSED WITH K-TRANS AND INITIAL AREA UNDER THE GADOLINIUM CONCENTRATION-TIME CURVE (IAUGC)

被引：0

作者：

Cher, Lawrence ^{[1
]}

Nowak, Anna ^{[2
]}

Iatropoulos, George ^{[1
]}

Lee, Weon Sup ^{[3
]}

Lee, Seon Young ^{[3
]}

Shim, Sang Ryeol ^{[3
]}

Yoo, Jin San ^{[3
]}

机构：

[1] Austin Hlth, Olivia Newton John Canc & Wellness Ctr, Heidelberg, Vic, Australia

[2] Sir Charles Gairdner Hosp, Perth, WA, Australia

[3] Pharmabcine, Chungbuk, South Korea

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

ACTR-75

引用

页码：17 / 17

页数：1